Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase 1/2 Dose Escalation Study of CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

Background: Acute lymphoblastic leukemia (ALL) is the most common cancer in children. About 90% of children and young adults who are treated for ALL can now b…

B-NHLB-Non Hodgkin LymphomaAcute Lymphocytic Leukemia+8 more

National Cancer Institute (NCI)NCT05442515